Dr Amrita Singh appointed to oversee the technical operations
Neuberg Diagnostics announced its expansion plans in Delhi and Kolkata in Q4FY21. Dr Amrita Singh, an experienced industry expert, has been appointed as Chief of Lab Services for the region. She will be overseeing the company’s expansion and technical operations in North and East India. For expansion in these two regions, the company plans to invest up to Rs 150 crores for organic and inorganic business growth.
Currently, with more than 80 labs and 1000 touchpoints, Neuberg Diagnostics is present in India, the UAE and South Africa. By onboarding, the top laboratories like Bengaluru-based Anand Diagnostics Laboratory; Ahmedabad-based Supratech Micropath; Pune-based AG Diagnostics; Chennai-based Ehrlich Lab; Dubai based Minerva Lab; and South Africa- based Global Lab – Neuberg has created a strong foothold in Gujarat, Tamil Nadu, Karnataka, Andhra Pradesh, Telangana, Maharashtra, and Kerala in India as well as in the UAE and South Africa.
The company aims to add another 10 labs in the next quarter and 30 labs by end of next fiscal. It also plans to commence commercial operations in the US in the next quarter.
Dr GSK Velu, CMD, Neuberg Diagnostics said, “We started with a mission to make advanced diagnostics accessible and affordable to everyone. With a commitment to provide affordable diagnostics, we are now rolling out our quality routine and referral lab testing services in North & East India. Additionally, we are aiming to launch new generation techniques that are deployed for diagnosing complicated diseases where deeper analysis is required. South and West have been our focus markets over the past three years. We are already leaders in markets like Karnataka, Gujarat, Tamil Nadu, Kerala and South Maharashtra, and are expanding our presence in other key markets like Andhra Pradesh and Telangana and Mumbai in Maharashtra by next quarter. Now, we want to be a significant player in North and East. In both regions, we are looking for organic and inorganic growth catering to the testing need.”
A Ganesan, Vice Chairman, Neuberg Diagnostics said, “Currently, through hospital lab management and customer walk-in centres, we already have a presence in Delhi NCR and Chandigarh. Bringing on board Dr Amrita Singh and a senior leadership team based in Delhi and Kolkata will provide the necessary management bandwidth and technical expertise to grow our operations in North and East India over the next two years. Our northern growth will be similar to South and West India, which has enabled us to become one of the top four diagnostics path lab players within three years of our operations, since Oct 2017.”
Neuberg Diagnostics actively performs 6000+ pathological tests. Currently, it is conducting COVID-19 tests at its 10 ICMR approved labs in the country.
